No insider purchase over the last 90 days. The latest was filed 02 Jul 2026.
This page follows insider dealings at Nyxoah as filed with FSMA based in Belgium. The group dates from 2009. The last twelve months, up to 18 October 2026, brought 24 filings signed by 16 insiders.
Purchases and sales both appear in the filings: 23 purchases (15 insiders, €25.6M) and 1 sale (1 insider, €2.4M). The net balance comes to €23.2M on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Biggest ticket of the year: €6.0M, bought by Taub Robert and made public on 18 June 2026. Among those who bought: 12 board members and 3 senior executives.
Compared with its exchange (77 companies, median 11 filings), a count of 24 filings is above the norm. Looking back to 2022, when coverage begins, insiders filed 58 purchases and 6 sales.
In the case of 22 purchases, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The last purchase on record was published on 2 July 2026, which is 108 days ago. The median gap between a trade and its publication by FSMA is 7 days. The regulation allows three business days to notify a trade (MAR article 19).
This summary is built from FSMA disclosures alone and does not predict where the share price will go.
Headquarters: Belgium · Founded: 2009
Source: Wikidata (CC0).
+13 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 64 declarations
Nyxoah is a company focused on developing innovative solutions for the treatment of sleep disorders. It is listed on the XBRU market.